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Introduction: Acute Lung Injury (ALI) with genetic predisposition is fatal. Relationship between
angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphism and the prognosis
of local Chinese patients with ALI was investigated; meanwhile, the mechanisms involved were
explored.
Methods: 101 ALI patients, 408 non-ALI patients and 236 healthy blood donors were enrolled.
ACE I/D polymorphism was detected by polymerase chain reaction, then ACE genotype (II, ID,
DD) and allele (I, D) frequencies were compared. Clinical data of ALI patients was calculated.
Also, peripheral blood mononuclear cells (PBMC) were isolated from healthy volunteers with
different ACE genotypes. Lipopolysaccharide (LPS)-induced ACE gene mRNA expression and
ACE activity was measured.
Results: There was no significant difference in the frequencies of the genotypes and alleles.
Acute Physiology and Chronic Health Evaluation (APACHE) II score was higher in DD subgroup
than in II subgroup (19.7  8.7 and 15.6  6.2; P < 0.05). The 28-day mortality was significantly
different (17.4%, 26.8%, and 64.3% for II, ID, and DD; P Z 0.013). DD genotype was the inde-
pendent prognostic factor for 28-day outcome. Furthermore, LPS-induced ACE mRNA expres-
sion and ACE activity from PBMC in DD genotype subgroup were both significantly higher
than those in the other two subgroups.
Conclusions: ACE I/D polymorphism is a prognostic factor for ALI. Patients with the DD geno-
type have higher mortality of ALI. Polymorphism influences the expression of ACE gene in
LPS-stimulated PBMC, DD genotype leads to higher level of mRNA and enzyme activity. It
may be one of the mechanisms involved.
ª 2011 Elsevier Ltd. All rights reserved.83272201.
o.com.cn (Y. Yang).
1 Elsevier Ltd. All rights reserved.
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Acute lung injury (ALI) with highmortality remains a common
disease in intensive care unit (ICU). Generally speaking,
infection is the primary cause, which induces excessive
cytokines from inflammatory cells and enhances inflamma-
tory response. Factors predicting the onset, severity or
outcome of this disease are not well known. Experimental
evidence suggests that activation of the renin-angiotensin
system (RAS), especial angiotensin (AT) may influence the
pathogenesis of ALI via affecting inflammation including
producing inflammatory factors and apoptosis.1 Angiotensin-
converting enzyme (ACE) is a key enzyme that converts AT-I
to AT-II. The human ACE gene is located on chromosome
17q23, while its polymorphism is consists of the presence
(insertion, I) and absence (deletion, D) of a 287-bp Alu
repeat sequence in intron 16.2 ACE I/D polymorphism has
been shown to influence the prognosis of acute respiratory
distress syndrome,2 and is different with various races and
districts.3 There was no report of ACE genotypes in the Han
Chinese with ALI in the district.
We therefore focusedon the relationship betweenACE I/D
polymorphismand theonset andprognosis of ALI. Andwealso
investigated the effects of ACE I/D genotypes on ACE level
from human peripheral blood mononuclear cells (PBMC).
Methods
Study population
The present study was approved by the Ethics Committee of
Zhongda Hospital, the Affiliated Hospital of Southeast
University (Nanjing, China). Over a period of one year,
patients over 18-year-old, which divided into two groups,
ALI and non-ALI patients, admitted to a specialized ICU of
Zhongda Hospital, were considered eligible for the study.
Healthy blood donors were healthy subjects’ donors during
the same period. All subjects were ethnical Chinese and
were not genetically related.
ALI patients fulfilled the joint American/European
Consensus Committee criteria for ALI: a) acute onset, b)
bilateral pulmonary infiltrations, c) impaired oxygenation
(PaO2/FiO2 of <300 mmHg), and d) pulmonary artery
occlusion pressure of <18mmHg, or no evidence of left
heart failure. Patients in the non-ALI group were all
admitted to the hospital over the same period due to other
diseases. Healthy controls were healthy blood donors. They
were all local Chinese with no gender differences. Exclu-
sion criteria were: a) history of ALI, b) received ACE
inhibitor or angiotensin receptor antagonist within one
month before the development of ALI, c) having liver or
renal failure in terminal stage, d) pregnancy or lactation, e)
malignant tumor or immunological disease, f) history of
bone marrow transplant or lung transplant, g) received
immunosuppressive drug, h) Glasgow Coma Scale (GCS) < 7.
Clinical data collection and outcome
The following data were collected from the ALI group: sex,
age, reason for admission, Acute Physiology and ChronicHealth Evaluation (APACHE) II scores, Sequential Organ
Failure Assessment (SOFA) sores, Lung Injury Scores (LIS),
PaO2/FiO2, duration of mechanical ventilation and vaso-
active agents, number of organ failure, duration of ICU stay
and 28-day mortality.
Determination of ACE genotypes
DNA was extracted from whole blood samples by modified
phenol-chloroform extraction. ACE genotype was deter-
mined by three-primer polymerase chain reaction (PCR)
amplification as described previously.4 This method yielded
amplification products of 83 bp for D allele and 65 bp for I
allele. Standard polymerase chain primer was performed
with three primers (50-CATCCTTTCTCCCATTTCTC-30, 50-ATT
TCAGAGCTGGAATAAAATT-30 and 50-TGGGATTACAGGCGTGA
TACAG-30). The DNA was amplified for 35-cycled with
denaturation at 94 C for 1 min, annealling at 53 C for
1 min, and extension at 72 C for 1 min, followed by final
extension at 72 C for 10 min. The PCR products were
identified on polyacrylamide gels. The genotypic distribu-
tions and allelic frequencies of ACE I/D polymorphism
among the three groups were calculated.
Preparation of PBMC
Peripheral blood mononuclear cells (PBMC) were separated
from whole blood of healthy blood donors by density
gradient centrifugation (LTS 1077, Hao Yang Biological
Manufacture Co. Ltd, Tianjin, China). The buffy coat layer
containing PBMC at the interface was carefully removed,
washed twice with phosphate-buffered saline (PBS) and
centrifuged at 1500 rpm for 10 min. The cells were sus-
pended in RPMI 1640 supplemented with 10% fetal bovine
serum (FBS; Life Technologies), and incubated in the
presence of 5% CO2 in air at 37
C in 24-well plates. After 6 h
or 24 h incubation period with or without LPS incubation
(final concentration of LPS 0.1 mg/ml), cells or supernatant
were collected.
Isolation of mRNA and RT-PCR
Total RNA was isolated from cultured PBMC cells using
TRNZOL (DP405-01, Tiangen Biological Manufacture Co. Ltd,
Beijing, China) according to the instruction from the
manufacture. After RNA was transcribed with TaKaRa
PrimeScript RT-PCR Kit (DRR014A, TAKARA Biotechnology
Co. Ltd, Dalian, China), PCR amplification of cDNA was
done. Primer pairs of ACE were 50- CAGGAGTGGA-
GACCGAGA-30(sense) and 50-CCAGACAAGCCCAACCTC -30(an
ti-sense) with a predicted size 394 bp. The cycle profile
included denaturation for 30 s at 94 C, annealing for 60 s at
59 C and extension for 40 s at 72 C. Human b-actin,
regarded as internal control for stable expression, was
amplified with primers of 50- CTGGAAGGTGGACAGCGAGG-
30(sense) and 50- TGACGTGGACATCCGCAAAG-30(anti-sense)
with a predicted size 207 bp. The cycle profile included
denaturation for 30 s at 94 C, annealing for 60 s at 53 C
and extention for 40 s at 72 C. The resulting densities of
the ACE bands were expressed relative to the correspond-
ing density of the actin band from the same RNA sample.
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The ACE activity of cultural cells supernatant was measured
by hydrolysis of hippuril-glycyl-glycine. Briefly, hippuroyl
glycyl-glycine was hydrolysis into hippuric acid and glycyl-
glycine by ACE. And hippuric acid was extracted by ethyl
acetate and distilled, then soluted in sodium chloride. The
mixture was monitored ultraviolet spectrophotometrically
at 228 nm.
Statistical analysis
The SPSS statistical package (version 13.0) was used for the
statistical analysis. Continuous data were expressed as
mean  SD. Comparisons of the continuous data were
performed by homogeneity test for variance firstly. Then
the data were analyzed by ANOVA or KruskaleWallis, Man-
neWhitney test. The chi-square tables were used to
compare the distribution of genotypes and alleles
frequencies. The 28-day survival rate among the genotype
groups was estimated by the KaplaneMeier method.
Multivariate logistic-regression analysis was used to assess
prognostic factors. For all test, a p value of ＜ 0.05 was
considered significant.Table 1 Clinical data of ALI patients (n Z 101, x  s).
Variables
Age, yrs
Male sex, n (%)
Causes of ALI, n (%)
Lung trauma
Pneumonia
Sepsis
Others
APACHEⅡ score
SOFA score
Lung injury score
PaO2/FiO2 (mm Hg)
Duration of mechanical ventilation (days)
Duration of vasoactive agents (days)
Number of organ failures
Duration of ICU Stay (days)
APACHE: Acute physiology and chronic health evaluation; SOFA: Seque
Table 2 Genotype and allele frequencies of ACE polymorphism
ALI (n Z 101) Non-ALI (n Z 408)
Genotype
II 46(45.6%) 158(38.7%)
ID 41(40.6%) 209(51.2%)
DD 14(13.8%) 41(10.1%)
Allele
I 65.8% 64.3%
D 34.2% 35.7%Results
Clinical data of ALI and non-ALI patients, and
control subjects
101 ALI patients (age, 65.1  16.5 yrs; 68 men and 33
women), 408 non-ALI patients and 236 healthy subjects
were enrolled. Clinical characteristics of ALI patients were
summarized in Table 1. The common causes of ALI patients
in this study were pneumonia (61.4%), sepsis (18.8%) and
trauma (12.9%).
Genotypes and allele frequencies of ACE
polymorphism data
Table 2 summarized the ACE genotype (II, ID, and DD) and
allele (I and D) frequencies of the three groups. DD geno-
type accounted for a similar percentage (13.8%, 10.1% and
9.8%, respectively; p＞ 0.05). The frequencies of D allele in
three groups were 34.2%, 35.7% and 32%, respectively.
Comparisons showed that there was no significant differ-
ence in the genotype and allele frequencies among these
groups.(n Z 101)
65.1  16.5
68 (67.3%)
13 (12.9%)
62 (61.4%)
19 (18.8%)
7 (6.9%)
16.6  6.9
7.9  3.8
1.33  0.66
201.9  56.6
5.4  6.4
2.5  3.1
2.5  1.2
10.7  8.9
ntial organ failure assessment; FiO2: fraction of inspired oxygen.
.
Normal control
(n Z 236)
p value
(ALI vs
Non-ALI)
p value
(ALI vs normal
control)
0.143 0.512
108(45.7%)
105(44.5%)
23(9.8%)
0.377 0.322
68%
32%
Table 3 Effect of ACE genotype polymorphism on the severity of ALI.
Genotype APACHEⅡ SOFA Number of
organ failure
Lung injury
score
During of
mechanical
ventilation (days)
Duration of
ICU stay (days)
Duration of
vasoactive
agent (days)
II 15.6  6.2 7.5  3.8 2.2  1.2 1.3  0.67 5.1  6.3 9.9  8.3 2.3  3.2
ID 16.6  6.8 7.9  3.4 2.6  1.1 1.3  0.65 5.3  6.9 11.4  9.5 2.4  3.1
DD 19.7  8.7a 9.4  4.3 2.8  1.2 1.4  0.70 6.4  5.2 11.3  9.6 3.8  2.8
Severity of illness scores was calculated on Day 1 of ALI. Values represent mean  standard deviation.
a p Z 0.048 compared with the ALI group.
Figure 1 Effect of ACE I/D genotype polymorphism on the
28-day survival rate of ALI (KaplaneMeier method). aP<0.05 vs
II subgroup and bP<0.05 vs ID subgroup.
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APACHE II score of DD genotype was 19.7  8.7, which was
significantly higher in the patients with II or ID genotype
(15.6  6.2 or 16.6  6.8). However, SOFA sore, LIS, PaO2/
FiO2, duration of mechanical ventilation and vasoactive
agents, number of organ failure, duration of ICU stay were
all similar among the three genotypes (Table 3).Table 4 Analyses of factors associated with 28-day mortality in
Variable
ACE DD genotype
APACHE II score
Number of organ failure
SOFA
Lung injury score
During of mechanical
ventilation
OR, odd ratio; 95% CI, 95% confidence interval; ACE, angiotensin-con
Evaluation II.Effect of ACE I/D polymorphism on the outcome of
ALI
The 28-day mortality of the ALI patients was 27.7%. The 28-
day mortality was significantly different among the three
ACE genotypes (17.4%, 26.8%, and 64.3% for II, ID, and DD,
respectively; pZ 0.013). Patients with the DD genotype had
a lower possibility of survival for 28 days as compared with
other groups (Fig. 1). Table 4 showed the results of survival
analysis and demonstrated that DD genotype (Odd ratio,
8.80; 95% confidence interval, 1.75e44.06; p Z 0.008) was
the significant independent prognostic factors for the 28-day
outcome.Expression of ACE mRNA of LPS-induced PBMC
After incubation for 6 h, ACE mRNA expressions of LPS-
induced PBMC with different genotypes were markedly
increased. Among the three genotypes, PBMC of DD geno-
type had the highest ACE mRNA expression after exposure
to LPS (30.55  13.14%, 15.92  6.11% and 18.76  8.69%
for DD genotype, II genotype and ID genotype group,
respectively, P Z 0.038) (Fig. 2A).ACE activity of LPS-induced PBMC
As shown in Fig. 2B, after incubation of LPS for 24 h, ACE
activity in cell cultured supernatant was higher than that in
control group (P < 0.05). The ACE activity of the PBMC with
DD genotype was significantly higher compared with that
with II genotype group, (60.76  24.55 U and
33.33  13.32 U, respectively, P Z 0.01). And The ACEpatients with ALI.
OR (95% CI) P value
8.80 (1.75e44.07) 0.008
1.03 (0.92e1.15) 0.622
1.15 (0.49e2.73) 0.745
1.34 (0.98e1.84) 0.067
2.60 (0.97e7.02) 0.059
1.05 (0.96e1.14) 0.293
verting enzyme; APACHE II, Acute Physiology and Chronic Health
Figure 2 Effect of ACE I/D genotype polymorphism on ACE
mRNA expression (A) and ACE activity (B) of LPS-induced PBMC.
PBMC was exposed to LPS (0.1 mg/ml) for 6 h, and then total
RNA was isolated and RT-PCR was performed. Also, the cellular
supernatant was collected for the following ACE activity
determination. Data are the mean  s.d. of three experiments.
aP<0.05 vs vehicle control, bP<0.05 vs II group.
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no significantly difference with other two genotype groups.
Discussion
It has been shown that there are marked ethnic differences
in the polymorphisms of the ACE gene.3 Reports from thewestern countries indicated that the D allele frequency was
usually higher than that of I allele, accounting for 51%e56%
in the general population,5 whereas in the Asian countries,
the frequency of the D allele was lower.3 In our study, the D
allele frequency of local Chinese was 32%e35.7%. As shown
in the reports from Singapore, Hong Kong, and Taiwan, the
D allele frequency among ethnic Chinese people was 30%e
45%. This may result in a smaller proportion of people
carrying the DD genotype, ranging from 9.8% to 13.8% in our
study, and it was similar to those previously reported in
Chinese ethnic populations, ranging from 9% to 16%.
Our study showed that the ALI patients with the DD geno-
type of the ACE gene had higher 28-daymortality. Meanwhile,
there was a similar distribution of genotypes and allele
frequencies of the ACE I/D gene in patients with ALI, non-ALI
and healthy control subjects. This study therefore suggested
that the polymorphism was associated with the outcome
rather than risk for ALI in the local Chinese population.
ACE I/D polymorphism was not associated with the
susceptibility of ALI in our finding. Just like many similar
studies suggested that the genotype was not an indepen-
dent risk factor.6,7 However, compared with both the CABG
(coronary artery bypass grafting) and ICU comparison
groups and the healthy population sample, the frequency of
the DD genotype and the D allele was markedly increased in
patients with ARDS, which may show this relationship in
ARDS.8 The differences may result from study object,
pathogeny and the degree of disease.9e11
As shown in many reports, there were associations
between ACE I/D polymorphism and prognosis of many dis-
eases.2,3,12e14 Our finding also indicated the patients with
the DD genotype were more emergent and had higher
mortality. DD genotype was the significant independent
prognostic factors for the 28-day outcome. Though cases in
the study were not sufficient, the proportions of the ACE
genotypes were similar to those previously reported in
Chinese ethnic groups. However, due to a relatively small
proportion of people carrying the DD genotype in the general
population among Asian people,more casesmay be required.
To investigate the underlying mechanism for improved
outcome, we focus on the diverse effect of gene expression
and enzyme activity in LPS-induced PBMC in-vitro. LPS is an
effective activator which may increase ACE mRNA expres-
sion and ACE activity in all genotypes. Among the three
genotypes, PBMC of DD genotype has the highest level after
exposure to LPS. It may be the pathway triggered due to ACE
polymorphism. It is well known that the renin-angiotensin
system play an important role in inflammation. AT has a pro-
inflammatory effect for the development or aggravation of
the systemic inflammatory response syndrome. ACE I/D
polymorphism had been shown to be associated with injury
to lung tissue in severe acute respiratory syndrome.15
Moreover, ACE plays a major role in the host defense
against invading pathogens.16 It is therefore that poly-
morphisms in the ACE gene may have an important effect on
determining the development and the outcome of ALI.Conclusions
ACE I/D polymorphism is a significant prognostic factor for
the outcome of ALI. Patients with the DD genotype have
1490 X.-M. Lu et al.a higher mortality rate of ALI. I/D polymorphism influences
the expression of ACE gene in LPS-stimulated PBMC, and DD
genotype leads to higher level of ACE mRNA and ACE
activity.
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